Position in BMY
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$729,181
-$60,724 QoQ
Shares Held
12,655
-2.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#1,327
of 2,506 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Derivatives in BMY
reported options exposure · as of Sep 30, 2025CallValue
$451
CallShares
10
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WNY Asset Management, LLC holds $12,807,497 across 8 Drug Manufacturers - General names. BMY ranks #6 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,610 | $6,728,802 | |
| 2 | JNJ |
Johnson & Johnson
|
6,393 | $1,623,630 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,678 | $1,372,123 | |
| 4 | ABBV |
AbbVie Inc.
|
4,347 | $1,093,879 | |
| 5 | PFE |
Pfizer Inc
|
33,220 | $799,937 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
12,655 | $729,181 | |
| 7 | NVO |
Novo Nordisk A S
|
5,198 | $249,192 | |
| 8 | AMGN |
Amgen Inc
|
582 | $210,753 |
All Filings in BMY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $729,181 | 12,655 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $789,905 | 13,024 | Shares | Sole | 2026-05-22 | |
| 2025-09-30 | $596,267 | 13,221 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $451 | 10 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $296,024 | 6,395 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $373,441 | 6,123 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $308,365 | 5,452 | Shares | Sole | 2025-02-21 | |
| 2024-09-30 | $418,162 | 8,082 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $354,292 | 8,531 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $437,202 | 8,062 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $411,660 | 8,023 | Shares | Sole | 2024-02-21 | |
| 2023-09-30 | $470,298 | 8,103 | Shares | Sole | 2023-12-14 | |
| 2023-06-30 | $451,231 | 7,056 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $502,358 | 7,248 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $547,683 | 7,612 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $538,222 | 7,571 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $584,430 | 7,590 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $580,150 | 7,944 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $507,653 | 8,142 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $560,339 | 9,470 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $550,396 | 8,237 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $474,043 | 7,509 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $287,881 | 4,641 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||